{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:56:10Z","timestamp":1784670970670,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2014.83","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T15:16:12Z","timestamp":1394118972000},"page":"e1110-e1110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["FAS system deregulation in T-cell lymphoblastic lymphoma"],"prefix":"10.1038","volume":"5","author":[{"given":"M","family":"Villa-Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Cobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Gonz\u00e1lez-Gugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"\u00c1lvarez-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Carracedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fern\u00e1ndez-Piqueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"key":"BFcddis201483_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.critrevonc.2010.12.003","volume":"79","author":"S Cortelazzo","year":"2011","unstructured":"Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D . Lymphoblastic lymphoma. Crit Rev Oncol Hematol 2011; 79: 330\u2013343.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFcddis201483_CR2","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1182\/blood-2012-12-474148","volume":"121","author":"BR Bonn","year":"2013","unstructured":"Bonn BR, Rohde M, Zimmermann M, Krieger D, Oschlies I, Niggli F et al. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood 2013; 121: 3153\u20133160.","journal-title":"Blood"},{"key":"BFcddis201483_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.critrevonc.2009.01.002","volume":"72","author":"L de Leval","year":"2009","unstructured":"de Leval L, Bisig B, Thielen C, Boniver J, Gaulard P . Molecular classification of T-cell lymphomas. Crit Rev Oncol Hematol 2009; 72: 125\u2013143.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFcddis201483_CR4","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1016\/S0021-9258(19)50076-X","volume":"267","author":"A Oehm","year":"1992","unstructured":"Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor\/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 1992; 267: 10709\u201310715.","journal-title":"J Biol Chem"},{"key":"BFcddis201483_CR5","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","volume":"75","author":"T Suda","year":"1993","unstructured":"Suda T, Takahashi T, Golstein P, Nagata S . Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169\u20131178.","journal-title":"Cell"},{"key":"BFcddis201483_CR6","doi-asserted-by":"publisher","first-page":"38241","DOI":"10.1074\/jbc.274.53.38241","volume":"274","author":"G Papoff","year":"1999","unstructured":"Papoff G, Hausler P, Eramo A, Pagano MG, Di Leve G, Signore A et al. Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J Biol Chem 1999; 274: 38241\u201338250.","journal-title":"J Biol Chem"},{"key":"BFcddis201483_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","volume":"76","author":"T Takahashi","year":"1994","unstructured":"Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969\u2013976.","journal-title":"Cell"},{"key":"BFcddis201483_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0092-8674(00)81266-0","volume":"85","author":"M Muzio","year":"1996","unstructured":"Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J et al. FLICE, a novel FADD-homologous ICE\/CED-3-like protease, is recruited to the CD95 (Fas\/APO-1) death\u2014inducing signaling complex. Cell 1996; 85: 817\u2013827.","journal-title":"Cell"},{"key":"BFcddis201483_CR9","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1093\/emboj\/16.10.2794","volume":"16","author":"JP Medema","year":"1997","unstructured":"Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997; 16: 2794\u20132804.","journal-title":"EMBO J"},{"key":"BFcddis201483_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1566524024605671","volume":"2","author":"S Baumann","year":"2002","unstructured":"Baumann S, Krueger A, Kirchhoff S, Krammer PH . Regulation of T cell apoptosis during the immune response. Curr Mol Med 2002; 2: 257\u2013272.","journal-title":"Curr Mol Med"},{"key":"BFcddis201483_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/978-0-387-89520-8_5","volume":"647","author":"M Ehrenschwender","year":"2009","unstructured":"Ehrenschwender M, Wajant H . The role of FasL and Fas in health and disease. Adv Exp Med Biol 2009; 647: 64\u201393.","journal-title":"Adv Exp Med Biol"},{"key":"BFcddis201483_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s001090000112","volume":"78","author":"M Muschen","year":"2000","unstructured":"Muschen M, Warskulat U, Beckmann MW . Defining CD95 as a tumor suppressor gene. J Mol Med (Berl) 2000; 78: 312\u2013325.","journal-title":"J Mol Med (Berl)"},{"key":"BFcddis201483_CR13","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/carcin\/bgq201","volume":"31","author":"M Villa-Morales","year":"2010","unstructured":"Villa-Morales M, Gonzalez-Gugel E, Shahbazi MN, Santos J, Fernandez-Piqueras J . Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility. Carcinogenesis 2010; 31: 2165\u20132171.","journal-title":"Carcinogenesis"},{"key":"BFcddis201483_CR14","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1038\/sj.onc.1209234","volume":"25","author":"M Villa-Morales","year":"2006","unstructured":"Villa-Morales M, Santos J, Fernandez-Piqueras J . Functional Fas (Cd95\/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma. Oncogene 2006; 25: 2022\u20132029.","journal-title":"Oncogene"},{"key":"BFcddis201483_CR15","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1158\/0008-5472.CAN-06-4006","volume":"67","author":"M Villa-Morales","year":"2007","unstructured":"Villa-Morales M, Santos J, Perez-Gomez E, Quintanilla M, Fernandez-Piqueras J . A role for the Fas\/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas. Cancer Res 2007; 67: 5107\u20135116.","journal-title":"Cancer Res"},{"key":"BFcddis201483_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00018-011-0866-4","volume":"69","author":"S Tauzin","year":"2012","unstructured":"Tauzin S, Debure L, Moreau JF, Legembre P . CD95-mediated cell signaling in cancer: mutations and post-translational modulations. Cell Mol Life Sci 2012; 69: 1261\u20131277.","journal-title":"Cell Mol Life Sci"},{"key":"BFcddis201483_CR17","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood.V91.10.3943","volume":"91","author":"C Beltinger","year":"1998","unstructured":"Beltinger C, Kurz E, Bohler T, Schrappe M, Ludwig WD, Debatin KM . CD95 (APO-1\/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood 1998; 91: 3943\u20133951.","journal-title":"Blood"},{"key":"BFcddis201483_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0301-472X(00)00623-8","volume":"29","author":"G Rozenfeld-Granot","year":"2001","unstructured":"Rozenfeld-Granot G, Toren A, Amariglio N, Brok-Simoni F, Rechavi G . Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies. Exp Hematol 2001; 29: 228\u2013233.","journal-title":"Exp Hematol"},{"key":"BFcddis201483_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","volume":"15","author":"JT den Dunnen","year":"2000","unstructured":"den Dunnen JT, Antonarakis SE . Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15: 7\u201312.","journal-title":"Hum Mutat"},{"key":"BFcddis201483_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jaci.2003.09.045","volume":"112","author":"F Altznauer","year":"2003","unstructured":"Altznauer F, von Gunten S, Spath P, Simon HU . Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations. J Allergy Clin Immunol 2003; 112: 1185\u20131190.","journal-title":"J Allergy Clin Immunol"},{"key":"BFcddis201483_CR21","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/cdd.2011.208","volume":"19","author":"M Chodorge","year":"2012","unstructured":"Chodorge M, Zuger S, Stirnimann C, Briand C, Jermutus L, Grutter MG et al. A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency. Cell Death Differ 2012; 19: 1187\u20131195.","journal-title":"Cell Death Differ"},{"key":"BFcddis201483_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1517\/14728222.2011.628937","volume":"16","author":"M Villa-Morales","year":"2012","unstructured":"Villa-Morales M, Fernandez-Piqueras J . Targeting the Fas\/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets 2012; 16: 85\u2013101.","journal-title":"Expert Opin Ther Targets"},{"key":"BFcddis201483_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935\u2013946.","journal-title":"Cell"},{"key":"BFcddis201483_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1172\/JCI43752","volume":"121","author":"A Magerus-Chatinet","year":"2011","unstructured":"Magerus-Chatinet A, Neven B, Stolzenberg MC, Daussy C, Arkwright PD, Lanzarotti N et al. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation. J Clin Invest 2011; 121: 106\u2013112.","journal-title":"J Clin Invest"},{"key":"BFcddis201483_CR25","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1182\/blood-2004-08-3104","volume":"106","author":"J Roesler","year":"2005","unstructured":"Roesler J, Izquierdo JM, Ryser M, Rosen-Wolff A, Gahr M, Valcarcel J et al. Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95{Delta}TM), is the basis for ALPS Ia in a family with duplicated 3' splice site AG in CD95 intron 5 on one allele. Blood 2005; 106: 1652\u20131659.","journal-title":"Blood"},{"key":"BFcddis201483_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1172\/JCI5121","volume":"103","author":"AK Vaishnaw","year":"1999","unstructured":"Vaishnaw AK, Orlinick JR, Chu JL, Krammer PH, Chao MV, Elkon KB . The molecular basis for apoptotic defects in patients with CD95 (Fas\/Apo-1) mutations. J Clin Invest 1999; 103: 355\u2013363.","journal-title":"J Clin Invest"},{"key":"BFcddis201483_CR27","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.4049\/jimmunol.154.6.2706","volume":"154","author":"I Cascino","year":"1995","unstructured":"Cascino I, Fiucci G, Papoff G, Ruberti G . Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 1995; 154: 2706\u20132713.","journal-title":"J Immunol"},{"key":"BFcddis201483_CR28","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1126\/science.7510905","volume":"263","author":"J Cheng","year":"1994","unstructured":"Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759\u20131762.","journal-title":"Science"},{"key":"BFcddis201483_CR29","first-page":"645","volume":"40","author":"CJ Watson","year":"2012","unstructured":"Watson CJ, O'Kane H, Maxwell P, Sharaf O, Petak I, Hyland PL et al. Identification of a methylation hotspot in the death receptor Fas\/CD95 in bladder cancer. Int J Oncol 2012; 40: 645\u2013654.","journal-title":"Int J Oncol"},{"key":"BFcddis201483_CR30","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/jid.2009.301","volume":"130","author":"CL Jones","year":"2010","unstructured":"Jones CL, Wain EM, Chu CC, Tosi I, Foster R, McKenzie RC et al. Downregulation of Fas gene expression in Sezary syndrome is associated with promoter hypermethylation. J Invest Dermatol 2010; 130: 1116\u20131125.","journal-title":"J Invest Dermatol"},{"key":"BFcddis201483_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1742-4658.2008.06790.x","volume":"276","author":"J Blomberg","year":"2009","unstructured":"Blomberg J, Ruuth K, Jacobsson M, Hoglund A, Nilsson JA, Lundgren E . Reduced FAS transcription in clones of U937 cells that have acquired resistance to Fas-induced apoptosis. FEBS J 2009; 276: 497\u2013508.","journal-title":"FEBS J"},{"key":"BFcddis201483_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00008390-200206000-00010","volume":"12","author":"RR Bullani","year":"2002","unstructured":"Bullani RR, Wehrli P, Viard-Leveugle I, Rimoldi D, Cerottini JC, Saurat JH et al. Frequent downregulation of Fas (CD95) expression and function in melanoma. Melanoma Res 2002; 12: 263\u2013270.","journal-title":"Melanoma Res"},{"key":"BFcddis201483_CR33","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/carcin\/bgi351","volume":"27","author":"WS Wang","year":"2006","unstructured":"Wang WS, Chen PM, Wang HS, Liang WY, Su Y . Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis 2006; 27: 1113\u20131120.","journal-title":"Carcinogenesis"},{"key":"BFcddis201483_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<127::AID-IJC5>3.0.CO;2-4","volume":"89","author":"M Mottolese","year":"2000","unstructured":"Mottolese M, Buglioni S, Bracalenti C, Cardarelli MA, Ciabocco L, Giannarelli D et al. Prognostic relevance of altered Fas (CD95)-system in human breast cancer. Int J Cancer 2000; 89: 127\u2013132.","journal-title":"Int J Cancer"},{"key":"BFcddis201483_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3109\/08880018.2011.557261","volume":"28","author":"AA Kennedy-Nasser","year":"2011","unstructured":"Kennedy-Nasser AA, Hanley P, Bollard CM . Hodgkin disease and the role of the immune system. Pediatr Hematol Oncol 2011; 28: 176\u2013186.","journal-title":"Pediatr Hematol Oncol"},{"key":"BFcddis201483_CR36","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1038\/bjc.2012.196","volume":"106","author":"Y Cimino","year":"2012","unstructured":"Cimino Y, Costes A, Damotte D, Validire P, Mistou S, Cagnard N et al. FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancer. Br J Cancer 2012; 106: 1989\u20131996.","journal-title":"Br J Cancer"},{"issue":"Suppl 1","key":"BFcddis201483_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1440-1746.2010.06582.x","volume":"26","author":"JM Schattenberg","year":"2011","unstructured":"Schattenberg JM, Schuchmann M, Galle PR . Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways. J Gastroenterol Hepatol 2011; 26 (Suppl 1): 213\u2013219.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFcddis201483_CR38","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1038\/sj.onc.1206399","volume":"22","author":"L Tourneur","year":"2003","unstructured":"Tourneur L, Mistou S, Michiels FM, Devauchelle V, Renia L, Feunteun J et al. Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells. Oncogene 2003; 22: 2795\u20132804.","journal-title":"Oncogene"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis201483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis201483","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:36:14Z","timestamp":1672961774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis201483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3]]}},"alternative-id":["BFcddis201483"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2014.83","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,6]]},"assertion":[{"value":"16 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}